nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—CYP19A1—Betamethasone—multiple sclerosis	0.0974	0.155	CbGbCtD
Methadone—CYP19A1—Dexamethasone—multiple sclerosis	0.0566	0.0903	CbGbCtD
Methadone—CYP2D6—Fingolimod—multiple sclerosis	0.0463	0.0738	CbGbCtD
Methadone—ABCB1—Methylprednisolone—multiple sclerosis	0.0317	0.0505	CbGbCtD
Methadone—CYP3A4—Fingolimod—multiple sclerosis	0.0294	0.0469	CbGbCtD
Methadone—HTR3A—area postrema—multiple sclerosis	0.0261	0.447	CbGeAlD
Methadone—CYP3A7—Dexamethasone—multiple sclerosis	0.0245	0.0391	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0245	0.0391	CbGbCtD
Methadone—CYP2C19—Prednisone—multiple sclerosis	0.0238	0.0379	CbGbCtD
Methadone—CYP2B6—Dexamethasone—multiple sclerosis	0.0234	0.0372	CbGbCtD
Methadone—ABCB1—Mitoxantrone—multiple sclerosis	0.0231	0.0368	CbGbCtD
Methadone—ABCB1—Betamethasone—multiple sclerosis	0.0206	0.0328	CbGbCtD
Methadone—ABCB1—Prednisolone—multiple sclerosis	0.0203	0.0324	CbGbCtD
Methadone—ABCB1—Prednisone—multiple sclerosis	0.0192	0.0306	CbGbCtD
Methadone—CYP3A4—Methylprednisolone—multiple sclerosis	0.019	0.0302	CbGbCtD
Methadone—CYP3A5—Dexamethasone—multiple sclerosis	0.0184	0.0293	CbGbCtD
Methadone—CYP2C8—Dexamethasone—multiple sclerosis	0.0177	0.0282	CbGbCtD
Methadone—CYP2C19—Dexamethasone—multiple sclerosis	0.0148	0.0237	CbGbCtD
Methadone—CYP3A4—Triamcinolone—multiple sclerosis	0.0144	0.0229	CbGbCtD
Methadone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0138	0.0221	CbGbCtD
Methadone—CYP2C9—Dexamethasone—multiple sclerosis	0.0123	0.0197	CbGbCtD
Methadone—CYP3A4—Betamethasone—multiple sclerosis	0.0123	0.0197	CbGbCtD
Methadone—CYP3A4—Prednisolone—multiple sclerosis	0.0122	0.0194	CbGbCtD
Methadone—ABCB1—Dexamethasone—multiple sclerosis	0.012	0.0191	CbGbCtD
Methadone—CYP3A4—Prednisone—multiple sclerosis	0.0115	0.0183	CbGbCtD
Methadone—CYP2D6—Dexamethasone—multiple sclerosis	0.0113	0.018	CbGbCtD
Methadone—ABCB1—Methotrexate—multiple sclerosis	0.00962	0.0153	CbGbCtD
Methadone—CYP3A4—Dexamethasone—multiple sclerosis	0.00718	0.0114	CbGbCtD
Methadone—HTR3A—nerve—multiple sclerosis	0.0034	0.0581	CbGeAlD
Methadone—OPRM1—nerve—multiple sclerosis	0.00312	0.0533	CbGeAlD
Methadone—HTR3A—brainstem—multiple sclerosis	0.00146	0.025	CbGeAlD
Methadone—GRIN3A—nervous system—multiple sclerosis	0.00146	0.0249	CbGeAlD
Methadone—GRIN3A—central nervous system—multiple sclerosis	0.0014	0.024	CbGeAlD
Methadone—OPRM1—brainstem—multiple sclerosis	0.00134	0.0229	CbGeAlD
Methadone—GRIN3A—brain—multiple sclerosis	0.00112	0.0191	CbGeAlD
Methadone—OPRD1—nervous system—multiple sclerosis	0.00103	0.0176	CbGeAlD
Methadone—OPRD1—central nervous system—multiple sclerosis	0.00099	0.0169	CbGeAlD
Methadone—OPRK1—nervous system—multiple sclerosis	0.000986	0.0168	CbGeAlD
Methadone—OPRK1—central nervous system—multiple sclerosis	0.000949	0.0162	CbGeAlD
Methadone—OPRK1—cerebellum—multiple sclerosis	0.000928	0.0159	CbGeAlD
Methadone—OPRM1—midbrain—multiple sclerosis	0.000853	0.0146	CbGeAlD
Methadone—OPRM1—spinal cord—multiple sclerosis	0.000832	0.0142	CbGeAlD
Methadone—Loperamide—POMC—multiple sclerosis	0.000814	0.699	CrCbGaD
Methadone—OPRD1—brain—multiple sclerosis	0.000786	0.0134	CbGeAlD
Methadone—HTR3A—nervous system—multiple sclerosis	0.000765	0.0131	CbGeAlD
Methadone—OPRK1—brain—multiple sclerosis	0.000753	0.0129	CbGeAlD
Methadone—HTR3A—central nervous system—multiple sclerosis	0.000736	0.0126	CbGeAlD
Methadone—OPRM1—nervous system—multiple sclerosis	0.000701	0.012	CbGeAlD
Methadone—OPRM1—central nervous system—multiple sclerosis	0.000675	0.0115	CbGeAlD
Methadone—CYP19A1—nervous system—multiple sclerosis	0.000589	0.0101	CbGeAlD
Methadone—HTR3A—brain—multiple sclerosis	0.000585	0.00999	CbGeAlD
Methadone—CYP19A1—central nervous system—multiple sclerosis	0.000567	0.0097	CbGeAlD
Methadone—CYP2D6—brainstem—multiple sclerosis	0.000537	0.00917	CbGeAlD
Methadone—OPRM1—brain—multiple sclerosis	0.000536	0.00916	CbGeAlD
Methadone—CYP19A1—brain—multiple sclerosis	0.00045	0.0077	CbGeAlD
Methadone—CYP2B6—nervous system—multiple sclerosis	0.000378	0.00647	CbGeAlD
Methadone—ABCB1—retina—multiple sclerosis	0.000372	0.00637	CbGeAlD
Methadone—CYP2B6—central nervous system—multiple sclerosis	0.000364	0.00623	CbGeAlD
Methadone—Ethopropazine—BCHE—multiple sclerosis	0.000351	0.301	CrCbGaD
Methadone—CYP2C8—brain—multiple sclerosis	0.000322	0.00551	CbGeAlD
Methadone—Bradycardia—Betamethasone—multiple sclerosis	0.000318	0.00154	CcSEcCtD
Methadone—Bradycardia—Dexamethasone—multiple sclerosis	0.000318	0.00154	CcSEcCtD
Methadone—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000317	0.00154	CcSEcCtD
Methadone—Body temperature increased—Azathioprine—multiple sclerosis	0.000317	0.00154	CcSEcCtD
Methadone—Abdominal pain—Azathioprine—multiple sclerosis	0.000317	0.00154	CcSEcCtD
Methadone—Tachycardia—Mitoxantrone—multiple sclerosis	0.000316	0.00153	CcSEcCtD
Methadone—Irritability—Methotrexate—multiple sclerosis	0.000313	0.00152	CcSEcCtD
Methadone—Vomiting—Cladribine—multiple sclerosis	0.000313	0.00152	CcSEcCtD
Methadone—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000313	0.00152	CcSEcCtD
Methadone—Rash—Cladribine—multiple sclerosis	0.000311	0.00151	CcSEcCtD
Methadone—Hallucination—Dexamethasone—multiple sclerosis	0.00031	0.00151	CcSEcCtD
Methadone—Hallucination—Betamethasone—multiple sclerosis	0.00031	0.00151	CcSEcCtD
Methadone—Dermatitis—Cladribine—multiple sclerosis	0.00031	0.00151	CcSEcCtD
Methadone—Weight increased—Prednisone—multiple sclerosis	0.000309	0.0015	CcSEcCtD
Methadone—Anorexia—Mitoxantrone—multiple sclerosis	0.000309	0.0015	CcSEcCtD
Methadone—Headache—Cladribine—multiple sclerosis	0.000309	0.0015	CcSEcCtD
Methadone—Arrhythmia—Triamcinolone—multiple sclerosis	0.000307	0.00149	CcSEcCtD
Methadone—Weight decreased—Prednisone—multiple sclerosis	0.000307	0.00149	CcSEcCtD
Methadone—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000307	0.00149	CcSEcCtD
Methadone—Hypotension—Mitoxantrone—multiple sclerosis	0.000303	0.00147	CcSEcCtD
Methadone—Visual impairment—Betamethasone—multiple sclerosis	0.000301	0.00146	CcSEcCtD
Methadone—Visual impairment—Dexamethasone—multiple sclerosis	0.000301	0.00146	CcSEcCtD
Methadone—Erythema—Triamcinolone—multiple sclerosis	0.000299	0.00145	CcSEcCtD
Methadone—Erythema—Methylprednisolone—multiple sclerosis	0.000299	0.00145	CcSEcCtD
Methadone—Hypersensitivity—Azathioprine—multiple sclerosis	0.000295	0.00143	CcSEcCtD
Methadone—Nausea—Cladribine—multiple sclerosis	0.000293	0.00142	CcSEcCtD
Methadone—Vertigo—Prednisolone—multiple sclerosis	0.000292	0.00142	CcSEcCtD
Methadone—Syncope—Prednisolone—multiple sclerosis	0.000292	0.00142	CcSEcCtD
Methadone—CYP2B6—brain—multiple sclerosis	0.000289	0.00494	CbGeAlD
Methadone—Somnolence—Mitoxantrone—multiple sclerosis	0.000288	0.0014	CcSEcCtD
Methadone—Loss of consciousness—Prednisolone—multiple sclerosis	0.000286	0.00139	CcSEcCtD
Methadone—CYP3A4—nervous system—multiple sclerosis	0.000286	0.00488	CbGeAlD
Methadone—Convulsion—Prednisolone—multiple sclerosis	0.000282	0.00137	CcSEcCtD
Methadone—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000282	0.00137	CcSEcCtD
Methadone—CYP2D6—nervous system—multiple sclerosis	0.000281	0.00481	CbGeAlD
Methadone—Arrhythmia—Dexamethasone—multiple sclerosis	0.000279	0.00135	CcSEcCtD
Methadone—Arrhythmia—Betamethasone—multiple sclerosis	0.000279	0.00135	CcSEcCtD
Methadone—Constipation—Mitoxantrone—multiple sclerosis	0.000277	0.00134	CcSEcCtD
Methadone—Pain—Mitoxantrone—multiple sclerosis	0.000277	0.00134	CcSEcCtD
Methadone—Bradycardia—Prednisone—multiple sclerosis	0.000277	0.00134	CcSEcCtD
Methadone—CYP3A4—central nervous system—multiple sclerosis	0.000275	0.0047	CbGeAlD
Methadone—Diarrhoea—Azathioprine—multiple sclerosis	0.000274	0.00133	CcSEcCtD
Methadone—Erythema—Betamethasone—multiple sclerosis	0.000272	0.00132	CcSEcCtD
Methadone—Erythema—Dexamethasone—multiple sclerosis	0.000272	0.00132	CcSEcCtD
Methadone—CYP2D6—central nervous system—multiple sclerosis	0.000271	0.00463	CbGeAlD
Methadone—Hallucination—Prednisone—multiple sclerosis	0.00027	0.00131	CcSEcCtD
Methadone—ABCB1—medulla oblongata—multiple sclerosis	0.000269	0.0046	CbGeAlD
Methadone—Vertigo—Triamcinolone—multiple sclerosis	0.000269	0.0013	CcSEcCtD
Methadone—Syncope—Triamcinolone—multiple sclerosis	0.000268	0.0013	CcSEcCtD
Methadone—Vertigo—Methylprednisolone—multiple sclerosis	0.000268	0.0013	CcSEcCtD
Methadone—Syncope—Methylprednisolone—multiple sclerosis	0.000268	0.0013	CcSEcCtD
Methadone—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000267	0.00129	CcSEcCtD
Methadone—Oedema—Prednisolone—multiple sclerosis	0.000266	0.00129	CcSEcCtD
Methadone—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000266	0.00129	CcSEcCtD
Methadone—Dizziness—Azathioprine—multiple sclerosis	0.000265	0.00129	CcSEcCtD
Methadone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000265	0.00128	CcSEcCtD
Methadone—CYP2D6—cerebellum—multiple sclerosis	0.000265	0.00452	CbGeAlD
Methadone—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000263	0.00128	CcSEcCtD
Methadone—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000263	0.00127	CcSEcCtD
Methadone—Shock—Prednisolone—multiple sclerosis	0.000261	0.00127	CcSEcCtD
Methadone—Convulsion—Triamcinolone—multiple sclerosis	0.000259	0.00126	CcSEcCtD
Methadone—Tachycardia—Prednisolone—multiple sclerosis	0.000259	0.00126	CcSEcCtD
Methadone—Convulsion—Methylprednisolone—multiple sclerosis	0.000259	0.00126	CcSEcCtD
Methadone—Urticaria—Mitoxantrone—multiple sclerosis	0.000257	0.00125	CcSEcCtD
Methadone—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000257	0.00125	CcSEcCtD
Methadone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000256	0.00124	CcSEcCtD
Methadone—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000256	0.00124	CcSEcCtD
Methadone—Vomiting—Azathioprine—multiple sclerosis	0.000255	0.00124	CcSEcCtD
Methadone—Anxiety—Methylprednisolone—multiple sclerosis	0.000253	0.00123	CcSEcCtD
Methadone—Drowsiness—Methotrexate—multiple sclerosis	0.000253	0.00123	CcSEcCtD
Methadone—Rash—Azathioprine—multiple sclerosis	0.000253	0.00123	CcSEcCtD
Methadone—Dermatitis—Azathioprine—multiple sclerosis	0.000252	0.00122	CcSEcCtD
Methadone—Flushing—Prednisone—multiple sclerosis	0.000252	0.00122	CcSEcCtD
Methadone—Headache—Azathioprine—multiple sclerosis	0.000251	0.00122	CcSEcCtD
Methadone—Dry mouth—Triamcinolone—multiple sclerosis	0.000249	0.00121	CcSEcCtD
Methadone—ABCB1—midbrain—multiple sclerosis	0.000246	0.0042	CbGeAlD
Methadone—Confusional state—Methylprednisolone—multiple sclerosis	0.000246	0.00119	CcSEcCtD
Methadone—Oedema—Triamcinolone—multiple sclerosis	0.000244	0.00119	CcSEcCtD
Methadone—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000244	0.00119	CcSEcCtD
Methadone—Vertigo—Betamethasone—multiple sclerosis	0.000244	0.00118	CcSEcCtD
Methadone—Vertigo—Dexamethasone—multiple sclerosis	0.000244	0.00118	CcSEcCtD
Methadone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000244	0.00118	CcSEcCtD
Methadone—Syncope—Dexamethasone—multiple sclerosis	0.000244	0.00118	CcSEcCtD
Methadone—Syncope—Betamethasone—multiple sclerosis	0.000244	0.00118	CcSEcCtD
Methadone—Arrhythmia—Prednisone—multiple sclerosis	0.000243	0.00118	CcSEcCtD
Methadone—Sweating—Methotrexate—multiple sclerosis	0.000243	0.00118	CcSEcCtD
Methadone—Shock—Triamcinolone—multiple sclerosis	0.00024	0.00117	CcSEcCtD
Methadone—Insomnia—Prednisolone—multiple sclerosis	0.00024	0.00117	CcSEcCtD
Methadone—ABCB1—spinal cord—multiple sclerosis	0.00024	0.0041	CbGeAlD
Methadone—Shock—Methylprednisolone—multiple sclerosis	0.00024	0.00116	CcSEcCtD
Methadone—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000239	0.00116	CcSEcCtD
Methadone—Loss of consciousness—Betamethasone—multiple sclerosis	0.000239	0.00116	CcSEcCtD
Methadone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000239	0.00116	CcSEcCtD
Methadone—Tachycardia—Triamcinolone—multiple sclerosis	0.000238	0.00116	CcSEcCtD
Methadone—Nausea—Azathioprine—multiple sclerosis	0.000238	0.00115	CcSEcCtD
Methadone—Tachycardia—Methylprednisolone—multiple sclerosis	0.000238	0.00115	CcSEcCtD
Methadone—Erythema—Prednisone—multiple sclerosis	0.000237	0.00115	CcSEcCtD
Methadone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000236	0.00115	CcSEcCtD
Methadone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000236	0.00114	CcSEcCtD
Methadone—Convulsion—Dexamethasone—multiple sclerosis	0.000235	0.00114	CcSEcCtD
Methadone—Convulsion—Betamethasone—multiple sclerosis	0.000235	0.00114	CcSEcCtD
Methadone—Asthenia—Mitoxantrone—multiple sclerosis	0.000232	0.00113	CcSEcCtD
Methadone—Anxiety—Betamethasone—multiple sclerosis	0.00023	0.00112	CcSEcCtD
Methadone—Anxiety—Dexamethasone—multiple sclerosis	0.00023	0.00112	CcSEcCtD
Methadone—Hypotension—Methylprednisolone—multiple sclerosis	0.000228	0.00111	CcSEcCtD
Methadone—Pain—Prednisolone—multiple sclerosis	0.000227	0.0011	CcSEcCtD
Methadone—Oedema—Dexamethasone—multiple sclerosis	0.000222	0.00108	CcSEcCtD
Methadone—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000222	0.00108	CcSEcCtD
Methadone—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000222	0.00108	CcSEcCtD
Methadone—Oedema—Betamethasone—multiple sclerosis	0.000222	0.00108	CcSEcCtD
Methadone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000222	0.00107	CcSEcCtD
Methadone—Insomnia—Triamcinolone—multiple sclerosis	0.000221	0.00107	CcSEcCtD
Methadone—Insomnia—Methylprednisolone—multiple sclerosis	0.00022	0.00107	CcSEcCtD
Methadone—Feeling abnormal—Prednisolone—multiple sclerosis	0.000219	0.00106	CcSEcCtD
Methadone—Visual impairment—Methotrexate—multiple sclerosis	0.000219	0.00106	CcSEcCtD
Methadone—Shock—Dexamethasone—multiple sclerosis	0.000218	0.00106	CcSEcCtD
Methadone—Shock—Betamethasone—multiple sclerosis	0.000218	0.00106	CcSEcCtD
Methadone—Agitation—Prednisone—multiple sclerosis	0.000217	0.00105	CcSEcCtD
Methadone—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000217	0.00105	CcSEcCtD
Methadone—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000217	0.00105	CcSEcCtD
Methadone—Tachycardia—Betamethasone—multiple sclerosis	0.000216	0.00105	CcSEcCtD
Methadone—Tachycardia—Dexamethasone—multiple sclerosis	0.000216	0.00105	CcSEcCtD
Methadone—CYP2D6—brain—multiple sclerosis	0.000215	0.00367	CbGeAlD
Methadone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000214	0.00104	CcSEcCtD
Methadone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000214	0.00104	CcSEcCtD
Methadone—Vertigo—Prednisone—multiple sclerosis	0.000213	0.00103	CcSEcCtD
Methadone—Syncope—Prednisone—multiple sclerosis	0.000212	0.00103	CcSEcCtD
Methadone—Anorexia—Dexamethasone—multiple sclerosis	0.000211	0.00103	CcSEcCtD
Methadone—Anorexia—Betamethasone—multiple sclerosis	0.000211	0.00103	CcSEcCtD
Methadone—Urticaria—Prednisolone—multiple sclerosis	0.000211	0.00102	CcSEcCtD
Methadone—Pain—Triamcinolone—multiple sclerosis	0.000209	0.00101	CcSEcCtD
Methadone—Loss of consciousness—Prednisone—multiple sclerosis	0.000208	0.00101	CcSEcCtD
Methadone—Hypotension—Betamethasone—multiple sclerosis	0.000207	0.001	CcSEcCtD
Methadone—Hypotension—Dexamethasone—multiple sclerosis	0.000207	0.001	CcSEcCtD
Methadone—Vomiting—Mitoxantrone—multiple sclerosis	0.000206	0.000999	CcSEcCtD
Methadone—Convulsion—Prednisone—multiple sclerosis	0.000205	0.000994	CcSEcCtD
Methadone—Rash—Mitoxantrone—multiple sclerosis	0.000204	0.000991	CcSEcCtD
Methadone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000204	0.00099	CcSEcCtD
Methadone—Chills—Methotrexate—multiple sclerosis	0.000204	0.000989	CcSEcCtD
Methadone—Headache—Mitoxantrone—multiple sclerosis	0.000203	0.000984	CcSEcCtD
Methadone—ABCB1—nervous system—multiple sclerosis	0.000202	0.00346	CbGeAlD
Methadone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000201	0.000977	CcSEcCtD
Methadone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000201	0.000975	CcSEcCtD
Methadone—Anxiety—Prednisone—multiple sclerosis	0.000201	0.000974	CcSEcCtD
Methadone—Insomnia—Dexamethasone—multiple sclerosis	0.000201	0.000973	CcSEcCtD
Methadone—Insomnia—Betamethasone—multiple sclerosis	0.000201	0.000973	CcSEcCtD
Methadone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000199	0.000967	CcSEcCtD
Methadone—Erythema—Methotrexate—multiple sclerosis	0.000198	0.000959	CcSEcCtD
Methadone—Hypersensitivity—Prednisolone—multiple sclerosis	0.000196	0.00095	CcSEcCtD
Methadone—ABCB1—central nervous system—multiple sclerosis	0.000195	0.00333	CbGeAlD
Methadone—Urticaria—Triamcinolone—multiple sclerosis	0.000194	0.000942	CcSEcCtD
Methadone—Urticaria—Methylprednisolone—multiple sclerosis	0.000194	0.00094	CcSEcCtD
Methadone—Body temperature increased—Triamcinolone—multiple sclerosis	0.000193	0.000937	CcSEcCtD
Methadone—Oedema—Prednisone—multiple sclerosis	0.000193	0.000937	CcSEcCtD
Methadone—Anaphylactic shock—Prednisone—multiple sclerosis	0.000193	0.000937	CcSEcCtD
Methadone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000193	0.000935	CcSEcCtD
Methadone—Decreased appetite—Betamethasone—multiple sclerosis	0.000193	0.000935	CcSEcCtD
Methadone—Decreased appetite—Dexamethasone—multiple sclerosis	0.000193	0.000935	CcSEcCtD
Methadone—Nausea—Mitoxantrone—multiple sclerosis	0.000192	0.000933	CcSEcCtD
Methadone—ABCB1—cerebellum—multiple sclerosis	0.00019	0.00325	CbGeAlD
Methadone—Shock—Prednisone—multiple sclerosis	0.00019	0.000921	CcSEcCtD
Methadone—Pain—Dexamethasone—multiple sclerosis	0.00019	0.00092	CcSEcCtD
Methadone—Pain—Betamethasone—multiple sclerosis	0.00019	0.00092	CcSEcCtD
Methadone—Tachycardia—Prednisone—multiple sclerosis	0.000188	0.000914	CcSEcCtD
Methadone—Hyperhidrosis—Prednisone—multiple sclerosis	0.000187	0.000905	CcSEcCtD
Methadone—Anorexia—Prednisone—multiple sclerosis	0.000184	0.000893	CcSEcCtD
Methadone—Feeling abnormal—Betamethasone—multiple sclerosis	0.000183	0.000886	CcSEcCtD
Methadone—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000183	0.000886	CcSEcCtD
Methadone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000181	0.000879	CcSEcCtD
Methadone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000181	0.000879	CcSEcCtD
Methadone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00018	0.000873	CcSEcCtD
Methadone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00018	0.000871	CcSEcCtD
Methadone—Vertigo—Methotrexate—multiple sclerosis	0.000178	0.000862	CcSEcCtD
Methadone—Urticaria—Betamethasone—multiple sclerosis	0.000176	0.000854	CcSEcCtD
Methadone—Urticaria—Dexamethasone—multiple sclerosis	0.000176	0.000854	CcSEcCtD
Methadone—Dizziness—Prednisolone—multiple sclerosis	0.000176	0.000852	CcSEcCtD
Methadone—Asthenia—Triamcinolone—multiple sclerosis	0.000175	0.00085	CcSEcCtD
Methadone—Body temperature increased—Dexamethasone—multiple sclerosis	0.000175	0.00085	CcSEcCtD
Methadone—Abdominal pain—Betamethasone—multiple sclerosis	0.000175	0.00085	CcSEcCtD
Methadone—Body temperature increased—Betamethasone—multiple sclerosis	0.000175	0.00085	CcSEcCtD
Methadone—Abdominal pain—Dexamethasone—multiple sclerosis	0.000175	0.00085	CcSEcCtD
Methadone—Asthenia—Methylprednisolone—multiple sclerosis	0.000175	0.000849	CcSEcCtD
Methadone—Insomnia—Prednisone—multiple sclerosis	0.000175	0.000847	CcSEcCtD
Methadone—Pruritus—Triamcinolone—multiple sclerosis	0.000173	0.000839	CcSEcCtD
Methadone—Pruritus—Methylprednisolone—multiple sclerosis	0.000172	0.000837	CcSEcCtD
Methadone—Convulsion—Methotrexate—multiple sclerosis	0.000171	0.000831	CcSEcCtD
Methadone—Decreased appetite—Prednisone—multiple sclerosis	0.000168	0.000814	CcSEcCtD
Methadone—Rash—Prednisolone—multiple sclerosis	0.000168	0.000813	CcSEcCtD
Methadone—Dermatitis—Prednisolone—multiple sclerosis	0.000167	0.000812	CcSEcCtD
Methadone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000167	0.000809	CcSEcCtD
Methadone—Headache—Prednisolone—multiple sclerosis	0.000166	0.000807	CcSEcCtD
Methadone—Constipation—Prednisone—multiple sclerosis	0.000165	0.000801	CcSEcCtD
Methadone—Confusional state—Methotrexate—multiple sclerosis	0.000163	0.000789	CcSEcCtD
Methadone—Dizziness—Triamcinolone—multiple sclerosis	0.000162	0.000784	CcSEcCtD
Methadone—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000161	0.000783	CcSEcCtD
Methadone—Dizziness—Methylprednisolone—multiple sclerosis	0.000161	0.000782	CcSEcCtD
Methadone—Feeling abnormal—Prednisone—multiple sclerosis	0.000159	0.000772	CcSEcCtD
Methadone—Asthenia—Dexamethasone—multiple sclerosis	0.000159	0.000772	CcSEcCtD
Methadone—Asthenia—Betamethasone—multiple sclerosis	0.000159	0.000772	CcSEcCtD
Methadone—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000158	0.000766	CcSEcCtD
Methadone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000158	0.000766	CcSEcCtD
Methadone—Nausea—Prednisolone—multiple sclerosis	0.000158	0.000766	CcSEcCtD
Methadone—Pruritus—Betamethasone—multiple sclerosis	0.000157	0.000761	CcSEcCtD
Methadone—Pruritus—Dexamethasone—multiple sclerosis	0.000157	0.000761	CcSEcCtD
Methadone—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000156	0.000757	CcSEcCtD
Methadone—Vomiting—Triamcinolone—multiple sclerosis	0.000155	0.000754	CcSEcCtD
Methadone—Vomiting—Methylprednisolone—multiple sclerosis	0.000155	0.000752	CcSEcCtD
Methadone—ABCB1—brain—multiple sclerosis	0.000155	0.00264	CbGeAlD
Methadone—Rash—Triamcinolone—multiple sclerosis	0.000154	0.000747	CcSEcCtD
Methadone—Dermatitis—Triamcinolone—multiple sclerosis	0.000154	0.000747	CcSEcCtD
Methadone—Anorexia—Methotrexate—multiple sclerosis	0.000154	0.000746	CcSEcCtD
Methadone—Rash—Methylprednisolone—multiple sclerosis	0.000154	0.000746	CcSEcCtD
Methadone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000154	0.000745	CcSEcCtD
Methadone—Urticaria—Prednisone—multiple sclerosis	0.000153	0.000744	CcSEcCtD
Methadone—Headache—Triamcinolone—multiple sclerosis	0.000153	0.000743	CcSEcCtD
Methadone—Headache—Methylprednisolone—multiple sclerosis	0.000153	0.000741	CcSEcCtD
Methadone—Abdominal pain—Prednisone—multiple sclerosis	0.000153	0.00074	CcSEcCtD
Methadone—Body temperature increased—Prednisone—multiple sclerosis	0.000153	0.00074	CcSEcCtD
Methadone—Diarrhoea—Dexamethasone—multiple sclerosis	0.000152	0.000736	CcSEcCtD
Methadone—Diarrhoea—Betamethasone—multiple sclerosis	0.000152	0.000736	CcSEcCtD
Methadone—Hypotension—Methotrexate—multiple sclerosis	0.000151	0.000731	CcSEcCtD
Methadone—Dizziness—Betamethasone—multiple sclerosis	0.000147	0.000711	CcSEcCtD
Methadone—Dizziness—Dexamethasone—multiple sclerosis	0.000147	0.000711	CcSEcCtD
Methadone—Insomnia—Methotrexate—multiple sclerosis	0.000146	0.000708	CcSEcCtD
Methadone—Nausea—Triamcinolone—multiple sclerosis	0.000145	0.000704	CcSEcCtD
Methadone—Nausea—Methylprednisolone—multiple sclerosis	0.000145	0.000702	CcSEcCtD
Methadone—Somnolence—Methotrexate—multiple sclerosis	0.000143	0.000696	CcSEcCtD
Methadone—Hypersensitivity—Prednisone—multiple sclerosis	0.000142	0.00069	CcSEcCtD
Methadone—Vomiting—Dexamethasone—multiple sclerosis	0.000141	0.000684	CcSEcCtD
Methadone—Vomiting—Betamethasone—multiple sclerosis	0.000141	0.000684	CcSEcCtD
Methadone—Decreased appetite—Methotrexate—multiple sclerosis	0.00014	0.00068	CcSEcCtD
Methadone—Rash—Dexamethasone—multiple sclerosis	0.00014	0.000678	CcSEcCtD
Methadone—Rash—Betamethasone—multiple sclerosis	0.00014	0.000678	CcSEcCtD
Methadone—Dermatitis—Dexamethasone—multiple sclerosis	0.00014	0.000677	CcSEcCtD
Methadone—Dermatitis—Betamethasone—multiple sclerosis	0.00014	0.000677	CcSEcCtD
Methadone—Headache—Dexamethasone—multiple sclerosis	0.000139	0.000674	CcSEcCtD
Methadone—Headache—Betamethasone—multiple sclerosis	0.000139	0.000674	CcSEcCtD
Methadone—Asthenia—Prednisone—multiple sclerosis	0.000139	0.000672	CcSEcCtD
Methadone—Pain—Methotrexate—multiple sclerosis	0.000138	0.000669	CcSEcCtD
Methadone—Pruritus—Prednisone—multiple sclerosis	0.000137	0.000663	CcSEcCtD
Methadone—Feeling abnormal—Methotrexate—multiple sclerosis	0.000133	0.000645	CcSEcCtD
Methadone—Diarrhoea—Prednisone—multiple sclerosis	0.000132	0.000641	CcSEcCtD
Methadone—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000132	0.00064	CcSEcCtD
Methadone—Nausea—Betamethasone—multiple sclerosis	0.000132	0.000639	CcSEcCtD
Methadone—Nausea—Dexamethasone—multiple sclerosis	0.000132	0.000639	CcSEcCtD
Methadone—Urticaria—Methotrexate—multiple sclerosis	0.000128	0.000622	CcSEcCtD
Methadone—Dizziness—Prednisone—multiple sclerosis	0.000128	0.000619	CcSEcCtD
Methadone—Body temperature increased—Methotrexate—multiple sclerosis	0.000128	0.000619	CcSEcCtD
Methadone—Abdominal pain—Methotrexate—multiple sclerosis	0.000128	0.000619	CcSEcCtD
Methadone—Vomiting—Prednisone—multiple sclerosis	0.000123	0.000595	CcSEcCtD
Methadone—Rash—Prednisone—multiple sclerosis	0.000122	0.000591	CcSEcCtD
Methadone—Dermatitis—Prednisone—multiple sclerosis	0.000122	0.00059	CcSEcCtD
Methadone—Headache—Prednisone—multiple sclerosis	0.000121	0.000587	CcSEcCtD
Methadone—Hypersensitivity—Methotrexate—multiple sclerosis	0.000119	0.000577	CcSEcCtD
Methadone—Asthenia—Methotrexate—multiple sclerosis	0.000116	0.000562	CcSEcCtD
Methadone—Nausea—Prednisone—multiple sclerosis	0.000115	0.000556	CcSEcCtD
Methadone—Pruritus—Methotrexate—multiple sclerosis	0.000114	0.000554	CcSEcCtD
Methadone—Diarrhoea—Methotrexate—multiple sclerosis	0.00011	0.000536	CcSEcCtD
Methadone—Dizziness—Methotrexate—multiple sclerosis	0.000107	0.000518	CcSEcCtD
Methadone—Vomiting—Methotrexate—multiple sclerosis	0.000103	0.000498	CcSEcCtD
Methadone—Rash—Methotrexate—multiple sclerosis	0.000102	0.000494	CcSEcCtD
Methadone—Dermatitis—Methotrexate—multiple sclerosis	0.000102	0.000493	CcSEcCtD
Methadone—Headache—Methotrexate—multiple sclerosis	0.000101	0.00049	CcSEcCtD
Methadone—Nausea—Methotrexate—multiple sclerosis	9.58e-05	0.000465	CcSEcCtD
Methadone—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.8e-05	0.000355	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—RRM1—multiple sclerosis	3.73e-05	0.000349	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	3.72e-05	0.000348	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.7e-05	0.000346	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	3.68e-05	0.000344	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	3.64e-05	0.000341	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	3.64e-05	0.000341	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	3.63e-05	0.000339	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	3.62e-05	0.000339	CbGpPWpGaD
Methadone—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.62e-05	0.000339	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—SRM—multiple sclerosis	3.59e-05	0.000336	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—SRM—multiple sclerosis	3.56e-05	0.000333	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	3.56e-05	0.000333	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	3.56e-05	0.000333	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CXCL10—multiple sclerosis	3.56e-05	0.000333	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	3.55e-05	0.000332	CbGpPWpGaD
Methadone—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.54e-05	0.000332	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CCL5—multiple sclerosis	3.49e-05	0.000327	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	3.48e-05	0.000325	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—CCR5—multiple sclerosis	3.47e-05	0.000324	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—IL2RA—multiple sclerosis	3.42e-05	0.00032	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CCL5—multiple sclerosis	3.37e-05	0.000316	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	3.34e-05	0.000313	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.33e-05	0.000312	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GPC5—multiple sclerosis	3.33e-05	0.000312	CbGpPWpGaD
Methadone—CYP2D6—Biological oxidations—POMC—multiple sclerosis	3.33e-05	0.000311	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	3.32e-05	0.00031	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	3.32e-05	0.00031	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	3.31e-05	0.00031	CbGpPWpGaD
Methadone—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.3e-05	0.000309	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.27e-05	0.000306	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GPC5—multiple sclerosis	3.26e-05	0.000305	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—BCHE—multiple sclerosis	3.22e-05	0.000302	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCL3—multiple sclerosis	3.19e-05	0.000298	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CCR5—multiple sclerosis	3.15e-05	0.000294	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—IL2RA—multiple sclerosis	3.1e-05	0.00029	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.08e-05	0.000288	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.08e-05	0.000288	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PTGER4—multiple sclerosis	3.07e-05	0.000287	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CCL5—multiple sclerosis	3.06e-05	0.000287	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—SRM—multiple sclerosis	3.04e-05	0.000285	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CCR5—multiple sclerosis	3.04e-05	0.000284	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PGR—multiple sclerosis	3.02e-05	0.000283	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.01e-05	0.000282	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	3.01e-05	0.000281	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—IL2RA—multiple sclerosis	3e-05	0.00028	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CXCR3—multiple sclerosis	2.97e-05	0.000277	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CD28—multiple sclerosis	2.94e-05	0.000275	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCR2—multiple sclerosis	2.89e-05	0.00027	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.86e-05	0.000268	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	2.85e-05	0.000267	CbGpPWpGaD
Methadone—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.82e-05	0.000264	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.82e-05	0.000264	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCL3—multiple sclerosis	2.8e-05	0.000262	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CCR5—multiple sclerosis	2.76e-05	0.000258	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—RRM1—multiple sclerosis	2.76e-05	0.000258	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.75e-05	0.000257	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.75e-05	0.000257	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL2RA—multiple sclerosis	2.72e-05	0.000254	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—POMC—multiple sclerosis	2.71e-05	0.000253	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.7e-05	0.000252	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PTGER4—multiple sclerosis	2.69e-05	0.000252	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.69e-05	0.000252	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.69e-05	0.000251	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.69e-05	0.000251	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CNR1—multiple sclerosis	2.66e-05	0.000249	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PGR—multiple sclerosis	2.65e-05	0.000248	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.61e-05	0.000244	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CXCR3—multiple sclerosis	2.6e-05	0.000243	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	2.59e-05	0.000242	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CD28—multiple sclerosis	2.58e-05	0.000241	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	2.57e-05	0.00024	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.53e-05	0.000237	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.53e-05	0.000237	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.53e-05	0.000237	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCR2—multiple sclerosis	2.53e-05	0.000237	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.52e-05	0.000235	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.51e-05	0.000235	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.51e-05	0.000235	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—BCHE—multiple sclerosis	2.47e-05	0.000231	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—POMC—multiple sclerosis	2.46e-05	0.00023	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GPC5—multiple sclerosis	2.46e-05	0.00023	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.45e-05	0.000229	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CCL2—multiple sclerosis	2.41e-05	0.000225	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CXCL10—multiple sclerosis	2.4e-05	0.000224	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—POMC—multiple sclerosis	2.38e-05	0.000222	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	2.36e-05	0.000221	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SRM—multiple sclerosis	2.35e-05	0.00022	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.34e-05	0.000219	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CNR1—multiple sclerosis	2.33e-05	0.000218	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	2.33e-05	0.000218	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.31e-05	0.000217	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	2.3e-05	0.000215	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.29e-05	0.000215	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	2.28e-05	0.000213	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PGR—multiple sclerosis	2.24e-05	0.00021	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	2.2e-05	0.000206	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—TYK2—multiple sclerosis	2.19e-05	0.000204	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CD28—multiple sclerosis	2.18e-05	0.000204	CbGpPWpGaD
Methadone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.18e-05	0.000204	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—POMC—multiple sclerosis	2.16e-05	0.000202	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.14e-05	0.000201	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.14e-05	0.000201	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—BCHE—multiple sclerosis	2.14e-05	0.000201	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	2.14e-05	0.0002	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CCL2—multiple sclerosis	2.11e-05	0.000197	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CXCL10—multiple sclerosis	2.1e-05	0.000197	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CD86—multiple sclerosis	2.1e-05	0.000196	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.1e-05	0.000196	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.09e-05	0.000195	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCL5—multiple sclerosis	2.06e-05	0.000193	CbGpPWpGaD
Methadone—ABCB1—Metabolism—RRM1—multiple sclerosis	2.04e-05	0.00019	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	2.01e-05	0.000188	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—IL2—multiple sclerosis	2e-05	0.000187	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	1.97e-05	0.000185	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.96e-05	0.000183	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—APOE—multiple sclerosis	1.94e-05	0.000181	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.92e-05	0.000179	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—TYK2—multiple sclerosis	1.92e-05	0.000179	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SPP1—multiple sclerosis	1.91e-05	0.000179	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.9e-05	0.000178	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.88e-05	0.000176	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.87e-05	0.000175	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCR5—multiple sclerosis	1.86e-05	0.000174	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CD86—multiple sclerosis	1.84e-05	0.000172	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.84e-05	0.000172	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL2RA—multiple sclerosis	1.83e-05	0.000171	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	1.82e-05	0.000171	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—IL2—multiple sclerosis	1.82e-05	0.00017	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.81e-05	0.00017	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCL5—multiple sclerosis	1.81e-05	0.000169	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	1.78e-05	0.000167	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	1.78e-05	0.000166	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—IL2—multiple sclerosis	1.76e-05	0.000164	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.75e-05	0.000164	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—APOE—multiple sclerosis	1.69e-05	0.000158	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SPP1—multiple sclerosis	1.68e-05	0.000157	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—POMC—multiple sclerosis	1.67e-05	0.000156	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.65e-05	0.000155	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.65e-05	0.000155	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCR5—multiple sclerosis	1.63e-05	0.000153	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.62e-05	0.000152	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	1.62e-05	0.000152	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.62e-05	0.000151	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL2RA—multiple sclerosis	1.61e-05	0.00015	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL2—multiple sclerosis	1.59e-05	0.000149	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.59e-05	0.000148	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.56e-05	0.000146	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CD86—multiple sclerosis	1.55e-05	0.000145	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.55e-05	0.000145	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	1.53e-05	0.000143	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CD80—multiple sclerosis	1.53e-05	0.000143	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—ALB—multiple sclerosis	1.52e-05	0.000142	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.51e-05	0.000142	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—APOE—multiple sclerosis	1.48e-05	0.000139	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	1.48e-05	0.000139	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—APOE—multiple sclerosis	1.48e-05	0.000139	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.48e-05	0.000138	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—POMC—multiple sclerosis	1.45e-05	0.000136	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCL2—multiple sclerosis	1.42e-05	0.000133	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.42e-05	0.000133	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	1.42e-05	0.000133	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—MAPK1—multiple sclerosis	1.39e-05	0.00013	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.39e-05	0.00013	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	1.38e-05	0.000129	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	1.36e-05	0.000127	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	1.35e-05	0.000126	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.34e-05	0.000126	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CD80—multiple sclerosis	1.34e-05	0.000125	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TYK2—multiple sclerosis	1.29e-05	0.000121	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—APOE—multiple sclerosis	1.29e-05	0.000121	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—POMC—multiple sclerosis	1.28e-05	0.000119	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—POMC—multiple sclerosis	1.27e-05	0.000119	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.27e-05	0.000119	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.27e-05	0.000119	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.26e-05	0.000118	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.25e-05	0.000117	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—APOE—multiple sclerosis	1.25e-05	0.000117	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCL2—multiple sclerosis	1.25e-05	0.000117	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—MAPK1—multiple sclerosis	1.22e-05	0.000114	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.2e-05	0.000112	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.18e-05	0.00011	CbGpPWpGaD
Methadone—ABCB1—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.000109	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—ALB—multiple sclerosis	1.16e-05	0.000109	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.16e-05	0.000108	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CD80—multiple sclerosis	1.13e-05	0.000106	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TYK2—multiple sclerosis	1.13e-05	0.000106	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—POMC—multiple sclerosis	1.11e-05	0.000104	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.1e-05	0.000103	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.09e-05	0.000102	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.08e-05	0.000101	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—POMC—multiple sclerosis	1.08e-05	0.000101	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL2—multiple sclerosis	1.07e-05	0.000101	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—IL6—multiple sclerosis	1.07e-05	0.0001	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	1.05e-05	9.86e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.03e-05	9.64e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MMP9—multiple sclerosis	1.02e-05	9.51e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—ALB—multiple sclerosis	1.01e-05	9.45e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.87e-06	9.24e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	9.57e-06	8.95e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—APOE—multiple sclerosis	9.54e-06	8.92e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL2—multiple sclerosis	9.42e-06	8.81e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL6—multiple sclerosis	9.37e-06	8.77e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.33e-06	8.73e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—APOE—multiple sclerosis	9.32e-06	8.72e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—STAT3—multiple sclerosis	9.04e-06	8.46e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MMP9—multiple sclerosis	8.92e-06	8.34e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MYC—multiple sclerosis	8.4e-06	7.86e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TGFB1—multiple sclerosis	8.38e-06	7.84e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK1—multiple sclerosis	8.22e-06	7.69e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—POMC—multiple sclerosis	8.19e-06	7.66e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—APOE—multiple sclerosis	8.07e-06	7.55e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—POMC—multiple sclerosis	8.01e-06	7.49e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL2—multiple sclerosis	7.96e-06	7.45e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—STAT3—multiple sclerosis	7.93e-06	7.42e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	7.92e-06	7.41e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	7.53e-06	7.05e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ALB—multiple sclerosis	7.47e-06	6.99e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MYC—multiple sclerosis	7.37e-06	6.89e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TGFB1—multiple sclerosis	7.35e-06	6.87e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ALB—multiple sclerosis	7.3e-06	6.83e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK1—multiple sclerosis	7.21e-06	6.74e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—APOE—multiple sclerosis	7.21e-06	6.74e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.2e-06	6.74e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—APOE—multiple sclerosis	7.03e-06	6.58e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—POMC—multiple sclerosis	6.94e-06	6.49e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	6.7e-06	6.27e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—APOE—multiple sclerosis	6.63e-06	6.2e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—APOE—multiple sclerosis	6.57e-06	6.15e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ALB—multiple sclerosis	6.32e-06	5.92e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL6—multiple sclerosis	6.31e-06	5.91e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MYC—multiple sclerosis	6.23e-06	5.82e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	6.21e-06	5.81e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—POMC—multiple sclerosis	6.19e-06	5.79e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	6.09e-06	5.7e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—POMC—multiple sclerosis	6.04e-06	5.65e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—POMC—multiple sclerosis	5.69e-06	5.33e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—POMC—multiple sclerosis	5.64e-06	5.28e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ALB—multiple sclerosis	5.64e-06	5.28e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—APOE—multiple sclerosis	5.61e-06	5.25e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL6—multiple sclerosis	5.54e-06	5.18e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ALB—multiple sclerosis	5.51e-06	5.15e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ALB—multiple sclerosis	5.19e-06	4.86e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ALB—multiple sclerosis	5.15e-06	4.81e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—POMC—multiple sclerosis	4.82e-06	4.51e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6—multiple sclerosis	4.68e-06	4.38e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ALB—multiple sclerosis	4.4e-06	4.11e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—APOE—multiple sclerosis	4.33e-06	4.05e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—POMC—multiple sclerosis	3.72e-06	3.48e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALB—multiple sclerosis	3.39e-06	3.18e-05	CbGpPWpGaD
